The University of Chicago Header Logo

Connection

Clayton Crawley to Drug Therapy

This is a "connection" page, showing publications Clayton Crawley has written about Drug Therapy.
Connection Strength

0.045
  1. DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-?B and sensitize to alkylating chemotherapy. BMC Biol. 2020 03 24; 18(1):32.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.